1,838
edits
Arrhythmogenic Right Ventricular Cardiomyopathy: Difference between revisions
Arrhythmogenic Right Ventricular Cardiomyopathy (view source)
Revision as of 04:27, 13 April 2010
, 13 April 2010no edit summary
Secretariat (talk | contribs) No edit summary |
Secretariat (talk | contribs) No edit summary |
||
| Line 58: | Line 58: | ||
</gallery> | </gallery> | ||
==Table 1== | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ Table 1. Comparison of Original and Revised Task Force Criteria | |+ Table 1. Comparison of Original and Revised Task Force Criteria | ||
| Line 104: | Line 105: | ||
** Ratio of RV end-diastolic volume to BSA ≥100 to <110 mL/m<sup>2</sup> (male) or ≥90 to <100 mL/m<sup>2</sup> (female) | ** Ratio of RV end-diastolic volume to BSA ≥100 to <110 mL/m<sup>2</sup> (male) or ≥90 to <100 mL/m<sup>2</sup> (female) | ||
** <em>or</em> RV ejection fraction >40% to ≤45% | ** <em>or</em> RV ejection fraction >40% to ≤45% | ||
|- | |||
| colspan="2" | II. Tissue characterization of wall | |||
|- | |||
| colspan="2" | Major | |||
|- | |||
| valign="top" | | |||
* Fibrofatty replacement of myocardium on endomyocardial biopsy | |||
| | |||
* Residual myocytes <60% by morphometric analysis (or <50% if estimated), with fibrous replacement of the RV free wall myocardium in ≥1 sample, with or without fatty replacement of tissue on endomyocardial biopsy | |||
|- | |||
| colspan="2" | Minor | |||
|- | |||
| | |||
| valign="top" | | |||
* Residual myocytes 60% to 75% by morphometric analysis (or 50% to 65% if estimated), with fibrous replacement of the RV free wall myocardium in ≥1 sample, with or without fatty replacement of tissue on endomyocardial biopsy | |||
|} | |} | ||